What does Average Directional Index Predict about Inovio Pharmaceuticals, Inc. (NASDAQ:INO)?

72

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) for the period of 9-Day stands at 13.11% while the stochastic %D for the same period stands at 12.65%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for Inovio Pharmaceuticals, Inc. (NASDAQ:INO) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indicator of a certain security, currently Inovio Pharmaceuticals, Inc. (NASDAQ:INO)’s 20-Day Bollinger Band indicates “Sell”.

About Company

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company’s electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. Inovio’s clinical programs include human papillomavirus (HPV)/cervical cancer (therapeutic), avian influenza (preventative), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) vaccines. It is advancing preclinical research for a universal seasonal/pandemic influenza vaccine. The Company’s partners and collaborators include University of Pennsylvania, National Microbiology Laboratory of the Public Health Agency of Canada, NIAID, Merck, ChronTech, University of Southampton, and HIV Vaccines Trial Network. Inovio Pharmaceuticals, Inc. is headquartered in Blue Bell, Pennsylvania.

Previous Day Activity Analysis

On the last trading day, Inovio Pharmaceuticals, Inc. (NASDAQ:INO) opened the session at $4.55 and after going down -5.27% closed at $4.31. The stock lost -0.24 points in the last trade.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO)’s stock fluctuated in the range of $4.20 and $4.55 during the previous active session. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) traded with the volume of 1.68 Million with average volume of 1.19 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 2.91 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.27 and 23.71 respectively.

Currently the Insider Ownership of the shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) is at 3.6% and the shares outstanding are 84.32 Million.

Important Ratio Analysis

Some important ratios to consider here for Inovio Pharmaceuticals, Inc. (NASDAQ:INO) are discussed below:

Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 8.67 and 2.63 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 3.95 and 0 correspondingly.

The Quick Ratio of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) stands at 3.9 while the Current Ratio depicts the value of 3.9.

Return on Assets ROA of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) is at -52.3% whereas, Return on Equity ROE and Return of Investment ROI of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) stand at -71.2% and -61.8% respectively.

Stock Performance Analysis

The stock performance of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) on the basis of 5 day trade show the dip of -18.83% whereas, the monthly performance of the stock shows decrease of -30.6%.

The quarterly performance of the stock remained in red zone with the value of -21.92% while six month performance of the shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) remained bearish with the count of -40.3%.

The yearly and YTD performance of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) remained down at -48.26% and -37.9% respectively.

LEAVE A REPLY